Operating Lease, Liability, Noncurrent of Inhibikase Therapeutics, Inc. from 30 Sep 2022 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Inhibikase Therapeutics, Inc. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 30 Sep 2022 to 30 Jun 2024.
  • Inhibikase Therapeutics, Inc. Operating Lease, Liability, Noncurrent for the quarter ending 30 Jun 2024 was $25,606, a 83% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

Inhibikase Therapeutics, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $25,606 -$124,365 -83% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $58,330 -$119,780 -67% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $90,124 -$115,327 -56% 31 Dec 2023 10-K 27 Mar 2024 2023 FY
Q3 2023 $121,013 -$111,007 -48% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $149,971 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $178,110 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $205,451 31 Dec 2022 10-K 31 Mar 2023 2022 FY
Q3 2022 $232,020 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.